Pubblicazioni

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric

STAT1 activation in association with JAK2 exon 12 mutations

2016 - HAEMATOLOGICA

Godfrey, Anna L.; Chen, Edwin; Massie, Charles E.; Silber, Yvonne; Pagano, Francesca; Bellosillo, Beatriz; Guglielmelli, Paola; Harrison, Claire N.; Reilly, John T.; Stegelmann, Frank; Bijou, Fontanet; Lippert, Eric; Boiron, Jean-Michel; DÃ£Â¶hner, Konstanze; Vannucchi, Alessandro M.; Besses, Carlos; Green, Anthony R.